Lymphoblastic Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoblastic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma [Phase 3]
A Phase 3 trial evaluating levocarnitine for protecting the liver during chemotherapy in various B-cell acute lymphoblastic leukemia and rel…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex) [Phase 2]
Phase 2 study of WU-CART-007, an allogeneic anti-CD7 CAR-T therapy, for T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma, is c…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating whether adding ponatinib to dose-adjusted EPOCH, with or without rituximab, improves outcomes in newly d…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors [NA]
A clinical trial update describing a high-intensity electronic health intervention aimed at reducing learning disparities among childhood ca…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies [Phase 2]
Phase 2 clinical trial evaluating MT2021-08T, a T-cell receptor alpha/beta-depleted donor peripheral blood stem cell product, for hematologi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy [Phase 3]
A Phase 3 trial evaluating adding inotuzumab ozogamicin to post-induction chemotherapy for high-risk acute lymphoblastic leukemia, mixed phe…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL [Phase 1, Phase 2]
This clinical trial is evaluating a nanobody-based CD19/CD22 tandem dual CAR-T cell therapy for relapsed/refractory precursor B-cell lymphob…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
A clinical trial registry update from Dana-Farber Cancer Institute notes a study involving questionnaires and tissue banking for multiple my…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial at the University of Chicago evaluating LP-118 with ponatinib, vincristine, and dexamethasone for relapsed/refrac…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: LBL-2016 for Children or Adolescents in China [Phase 3]
Phase 3 clinical trial in China evaluating treatment for lymphoblastic lymphoma in children/adolescents; currently active but not recruiting…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]
A Phase 2 clinical trial of Asparaginase Erwinia chrysanthemi in combination with chemotherapy for high-risk adults with newly diagnosed acu…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Venetoclax Basket Trial for High Risk Hematologic Malignancies [Phase 1]
A Phase 1 Venetoclax basket trial across multiple high-risk hematologic malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma [Phase 3]
Ongoing Phase 3 clinical trial evaluating levocarnitine to protect the liver from chemotherapy in children with acute lymphoblastic leukemia…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of capivasertib, venetoclax, and low-intensity chemotherapy in adults with acute ly…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma [Phase 4]
Phase 4 clinical trial update from St. Jude focusing on identifying information needed to guide treatment induction in newly diagnosed acute…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias [Phase 1, Phase 2]
Clinical trial update on an anti-CD19 CAR-T cell therapy being evaluated in Phase 1/Phase 2 for various leukemias and lymphoid cancers; recr…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT [NA]
Clinical trial update indicates ongoing recruitment for a study evaluating CD45RA-depleted peripheral stem cell addback to prevent viral or …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia [Phase 2]
Phase 2 clinical trial update describing a combination chemotherapy regimen for relapsed or refractory acute lymphoblastic leukemia, lymphob…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study
A Mayo Clinic-sponsored pilot clinical trial is evaluating how calaspargase pegol impacts the coagulation system in pediatric acute lymphobl…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma [Phase 2]
A Phase 2 clinical trial update from St. Jude Children's Research Hospital recruiting for therapy in newly diagnosed B-cell precursor acute …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation [NA]
The document updates a clinical trial evaluating an electronic health mindfulness-based music therapy intervention for patients undergoing a…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of CTD402 in T-ALL/LBL Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CTD402 in patients with T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma is currently re…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma [NA]
This clinical trial update describes a non-pharmacologic High-Intensity Parent Intervention Program aimed at improving learning and school f…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia [NA]
A clinical trial evaluating a mobile health tool to help adolescents and young adults with acute lymphoblastic leukemia and lymphoblastic ly…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: CAYA Cancer Retrospective Cohort Study
An ongoing retrospective cohort study titled CAYA Cancer, sponsored by Resonance, Inc., is currently recruiting to study Acute Lymphoblastic…